This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Cellphire, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ying Yi Zheng: Innovator in Anti-Cancer Technology
Introduction
Ying Yi Zheng is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical technology, particularly in the development of innovative methods for cancer treatment. His work focuses on enhancing the efficacy of anti-cancer agents through advanced delivery systems.
Latest Patents
Ying Yi Zheng holds 1 patent for his invention titled "Platelets loaded with anti-cancer agents." This patent describes a method of preparing cargo-loaded platelets. The process involves treating platelets with a cargo and a loading buffer that includes a salt, a base, a loading agent, and optionally ethanol, to create the cargo-loaded platelets. This innovative approach aims to improve the delivery of anti-cancer agents directly to targeted cells.
Career Highlights
Ying Yi Zheng is currently associated with Cellphire, Inc., a company that specializes in developing innovative solutions for blood and platelet storage and transportation. His work at Cellphire has positioned him as a key player in the advancement of medical technologies aimed at improving patient outcomes.
Collaborations
Ying Yi Zheng has collaborated with notable professionals in his field, including Keith Andrew Moskowitz and Rafael Jorda. These collaborations have contributed to the development of cutting-edge technologies and methodologies in cancer treatment.
Conclusion
Ying Yi Zheng's contributions to the field of anti-cancer technology through his innovative patent and work at Cellphire, Inc. highlight his commitment to advancing medical science. His efforts in developing cargo-loaded platelets represent a significant step forward in targeted cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile